Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2013
11/19/2013CA2739888C Spirocyclic gpr40 modulators
11/19/2013CA2622472C Dipeptidyl peptidase inhibitors for treating diabetes
11/19/2013CA2539403C 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
11/14/2013WO2013170146A1 Methods and compositions for modulating mir-204 activity
11/14/2013WO2013170115A1 Pyridazine and pyridine derivatives as nampt inhibitors
11/14/2013WO2013169886A1 Anti-pcsk9 antibodies and use thereof
11/14/2013WO2013169860A1 Fumigillol type compounds and methods of making and using same
11/14/2013WO2013169857A1 Treating hypothalamic obesity with metap2 inhibitors
11/14/2013WO2013169727A1 Polymorphic salt of the oxalate salt of 6 - o - ( 4 - dimethylaminoethoxy) cinnarnoyl fumagillol and methods of making and using same
11/14/2013WO2013169648A1 Pharmaceutical combinations comprising a dgat1 inhibtor and a triglyceride lowering drug
11/14/2013WO2013169547A1 Treatment for comorbid diabetes with chronic kidney disease
11/14/2013WO2013169546A1 Pyrazole compounds as sglt1 inhibitors
11/14/2013WO2013169007A1 Sustained-release complex preparations for treating diabetes with improved drug compliance and method for preparing same
11/14/2013WO2013168826A1 Method for screening for prophylactic or therapeutic agent for diseases or disorders associated with inflammation-related feedback loop
11/14/2013WO2013168760A1 Aromatic ring compound
11/14/2013WO2013168759A1 Aromatic ring compound
11/14/2013WO2013168694A1 Non-sugar energy-production-enhancing agent
11/14/2013WO2013168455A1 Synergistic antidiabetic therapeutic agent
11/14/2013WO2013168016A1 Compositions and methods for the treatment of metabolic syndrome
11/14/2013WO2013168007A1 Compositions and methods for the treatment of cardiovascular and neurological diseases
11/14/2013WO2013168003A1 Compositions and methods for the treatment of inflammation
11/14/2013WO2013168002A1 Compositions and methods for the treatment of neurological conditions
11/14/2013WO2013167996A1 Compositions and methods for the treatment of metabolic syndrome
11/14/2013WO2013167992A1 Compositions and methods for the treatment of inflammatory disorders
11/14/2013WO2013167991A1 Compositions and methods for the treatment of metabolic disorders
11/14/2013WO2013167635A1 Therapeutic use of indole-dihydro-imidazole derivatives
11/14/2013WO2013167620A1 Immunomodulatory methods using notch agonists
11/14/2013WO2013167554A1 Pharmaceutical combinations for the treatment of metabolic disorders
11/14/2013WO2013167514A1 New 2,3-dihydro-furo[2,3-c]pyridines, their use as modulators of the g-protein-coupled receptor gpr119 and pharmaceutical compositions comprising them
11/14/2013WO2013167403A1 Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
11/14/2013WO2013166621A1 1-(dihydronaphthalenyl)pyridones as melanin-concentrating hormone receptor 1 antagonists
11/14/2013WO2013166563A1 Method for producing a plant extract from desmodium and extract thereof
11/14/2013WO2013103919A3 Compositions and methods for treating metabolic disorders
11/14/2013WO2012154679A8 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
11/14/2013US20130303531 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
11/14/2013US20130303518 Methods of Inhibiting the Catalytic Activity of a Protein Kinase and of Treating a Protein Kinase Related Disorder
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303465 Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors
11/14/2013US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors
11/14/2013US20130302448 Phytin aqueous solution and use of said solution for the preparation of a liquid nutritional supplement or a cosmetic composition
11/14/2013US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt
11/14/2013CA2873087A1 Compositions and methods for the treatment of hyperglycemia
11/13/2013EP2662081A1 Therapeutic use of indole-dihydro-imidazole derivatives
11/13/2013EP2661438A2 New bicyclic compound for modulating g protein-coupled receptors
11/13/2013EP2661436A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
11/13/2013EP2661431A2 Heterocyclic compounds for the inhibition of pask
11/13/2013EP2661282A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
11/13/2013EP2661266A2 Chemosensory receptor ligand-based therapies
11/13/2013EP2661256A1 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
11/13/2013EP2661181A1 Food composition made of an algae extract for treating and/or preventing diabetic retinopathy
11/13/2013CN103391939A Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
11/13/2013CN103391934A Dipyridylamine derivative
11/13/2013CN103391932A Heterocyclic compounds for the inhibition of pask
11/13/2013CN103391928A 1,4-oxazepines as bace1 and/or bace2 inhibitors
11/13/2013CN103391786A Apolipoprotein A-IV as an antidiabetic peptide
11/13/2013CN103387928A Processing method of blackberry phyllanthus emblica fruit vinegar
11/13/2013CN103387602A Novel open-chain tetrapeptide analogue and preparation method and use thereof
11/13/2013CN103386119A Application of SIRT1 in adjusting rhythm and improving rhythm disorder
11/13/2013CN103386083A Pharmaceutical composition for treating type II diabetes
11/13/2013CN103386040A Hypoglycemic traditional Chinese medicine preparation and preparation method thereof
11/13/2013CN103386017A Medlar-nourishing amino acid oral solution for nourishing kidney and replenishing essence and preparation process thereof
11/13/2013CN103386015A A traditional Mongolian medicine for the treatment of diabetes
11/13/2013CN103386014A Traditional Chinese medicine decoction for treating diabetes and preparation method thereof
11/13/2013CN103385990A Rhizoma alismatis essence and preparation method thereof
11/13/2013CN103385972A Traditional Chinese medicine containing radix astragali and preparation method thereof
11/13/2013CN103385968A Traditional Chinese medicine containing pseudo-ginseng powder and preparation method thereof
11/13/2013CN103385967A Fleece-flower root-containing traditional Chinese medicine preparation and preparation method thereof
11/13/2013CN103385933A Catechu-containing traditional Chinese medicine preparation and preparation method thereof
11/13/2013CN103385931A Blood-sugar-lowering medicine composition
11/13/2013CN103385913A Radix Astragali extract and its preparation method and preparation
11/13/2013CN103385904A Chrysanthemum decocting pill and preparation process thereof
11/13/2013CN103385903A Stevia rebaudiana phenol extract and application thereof in preparing lipid-lowering products
11/13/2013CN103385896A Preparation method of bacterial cellulose composite flavonoid compound
11/13/2013CN103385894A Buccal tablets prepared from ganoderma broken-down wall spore powder
11/13/2013CN103385889A Carbohydrate and electrolyte mixed injection and preparation method thereof
11/13/2013CN103385885A Carbohydrate inhibitor used for treating diabetes
11/13/2013CN103385883A Pharmaceutical composition containing tropisetron hydrochloride and fructose
11/13/2013CN103385882A Sodium ibandronate injection composition
11/13/2013CN103385878A Repaglinide and dimethyldiguanide pharmaceutical composition and preparation method thereof
11/13/2013CN103385816A Waist-thinning slimming compound essential oil
11/13/2013CN103385513A Anti-renal failure traditional Chinese medicine health-care tonic semi-fluid extract
11/13/2013CN103385322A Blood fat-reduction and blood pressure-reduction tea
11/13/2013CN102936561B Health white spirit
11/13/2013CN102936560B Health-care yellow wine
11/13/2013CN102846720B Composite for lowering blood fat and improving anoxia endurance
11/13/2013CN102655866B Therapeutic or prophylactic agent for diabetes
11/13/2013CN102641310B 一种鸦胆子油栓剂 One kind javanica oil suppositories
11/13/2013CN102631466B Health care product for regulating blood lipid and preparation method thereof
11/13/2013CN102617745B Preparation method and blood sugar lowering function of Ganoderma lucidum karst polysaccharide F31
11/13/2013CN102552465B Quality test method for hawthorn leaf medicine, hawthorn leaf extractives or products
11/13/2013CN102526103B Multi-trace element injection and preparation method thereof
11/13/2013CN102526057B Quinazoline derivative as pgk1 (phosphoglycerate kinase 1) activator
11/13/2013CN102488810B Applications of huoxiangzhengqi soft capsule serving as medicinal preparations for treating cardiovascular and cerebrovascular diseases
11/13/2013CN102440975B Metformin hydrochloride sustained-release tablets and preparation method thereof
11/13/2013CN102416112B Chinese medicinal composition for treating diabetes
11/13/2013CN102399378B Temperature sensitive chitosan hydrogel and preparation method thereof
11/13/2013CN102349920B Sulfanilamide medicament composition for wound surface
11/13/2013CN102321170B Liraglutide variant and conjugate thereof
11/13/2013CN102260617B Royal jelly specially-produced wine and preparation technology thereof
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 1298